Table 2.
Linkages identified in the (E3 × DA)DA rat CIA experiment and previously identified PIA loci*
Phenotype, SSLP marker | LOD | Inheritance† | CIA QTL‡ | PIA QTL‡ | Other QTLs | ||
---|---|---|---|---|---|---|---|
QTL | Ref. | QTL | Ref. | ||||
Maximum arthritis score | |||||||
D3mit6 | 3.5 | DA | Cia11 | 20 | – | – | – |
D4rat109 | 4.7 | DA | Cia3 | 22 | Pia5 | 16 | Aia3, Eau1 |
D4eno2 | 7.5 | DA | Cia13 | 20 | Pia7 | 17 | Oia2, Ciaa4 |
D12rat72 | 6.6 | DA | Cia12 | 20 | Pia4 | 16 | Eae5, Eau2 |
Arthritis onset | |||||||
D3mit6 | 2.8 | DA | Cia11 | 20 | – | – | – |
D4rat109 | 5.2 | DA | Cia3 | 22 | Pia5 | 16 | Aia3, Eau1 |
D4eno2 | 10.8 | DA | Cia13 | 20 | Pia7 | 17 | Oia2, Ciaa4 |
D6mgh10 | 2.9 | E3 | Cia20 | – | Pia3 | 16 | – |
D12rat72 | 7.6 | DA | Cia12 | 20 | Pia4 | 16 | Eae5, Eau2 |
COMP | |||||||
D4eno2 | 4.0 | DA | Cia13 | 20 | Pia7 | 17 | Oia2, Ciaa4 |
D12rat72 | 3.6 | DA | Cia12 | 20 | Pia4 | 16 | Eae5, Eau2, Apr1 |
α1‐acid glycoprotein | |||||||
D4eno2 | 5.1 | DA | Cia13 | 20 | Pia7 | 17 | Oia2, Ciaa4 |
D12rat72 | 8.3 | DA | Cia12 | 20 | Pia4 | 16 | Eae5, Eau2, Apr1 |
Anti‐CII IgG | |||||||
D1mgh11 | 3.3 | DA | Ciaa6 | – | – | – | Eae6, Eae7 |
D20mgh4 | 5.8 | E3 | Ciaa1 | 22 | Pia1 | 10 | Cia1, Eae1, Oia1 |
IgG rheumatoid factors | |||||||
D5rat37 | 3.0 | DA | Ciaa5 | 19 | – | – | Apr2 |
D14wox12 | 3.2 | DA | Ciaa7 | – | Pia6 | 16 | Eae10 |
The maximum arthritis score represents the maximum clinical score obtained during the experiment. Arthritis onset represents the first day of visible signs of arthritis after induction of type II collagen–induced arthritis (CIA). Plasma levels of cartilage oligomeric matrix protein (COMP), α1‐acid glycoprotein, anti–type II collagen (anti‐CII) IgG (reactive with rat type II collagen), and IgG rheumatoid factors were measured as described in Materials and Methods. SSLP = simple sequence‐length polymorphism; PIA = pristane‐induced arthritis; LOD = logarithm of odds; QTL = quantitative trait locus.
Inheritance pattern determined as being DA or E3 promoting.